Tapping Recession-Proof Stocks to Fight the Bear (SNPS, KEGS, SAM, ABT, NEE, HD, ACN, TAP)

Fed Chair Jay Powell took a trip to Capitol Hill this week for his regular interrogation by Congress – no doubt a tough trip to take for a guy already under incredible pressure for missing the mark on the Fed’s policy stance where inflation risk was concerned last year. That has now blossomed into the […]

The Huge Opportunity in Diagnostic Testing Stocks (LH, GDBY, ABT, BIO, CVS, EPWCF, WBA)

Despite its tragic human toll, the pandemic accomplished a number of major societal leaps, including deregulating telehealth, penetrating delivery and virtual communications markets across the population, and fast-forwarding our vaccine industry by possibly decades in terms of collaboration and technical innovation. But one area of the market that has also been powered to new growth […]

Testing Stocks on the Radar as Endemic Covid Sets In (TMO, ABT, HOLX, FLGT, LHDX, ALST, RHHBY)

The dream of truly being in a post-Covid-19 world is finally beginning to fade away with the rise of the Delta variant. The future appears more and more set on “management of an endemic pathogen” than the eradication of this foe. It will always find somewhere to hide out and mutate, according to many experts. […]

Abbott Laboratories (NYSE:ABT) May Face Legal Action – ABBV

Boston, MA 10/24/2013 (wallstreetpr) – An investigation has been launched by a law firm into potential violations of securities laws concerning the demerger of Abbott Laboratories (NYSE:ABT) and AbbVie Inc (NYSE:ABBV). Abbott had announced the demerger in October 2011 as the businesses had evolved in two separate entities. Abbott would continue to focus on drug manufacturing and […]

Abbott Laboratories (NYSE:ABT) Charm Investors With 75% Hike In Dividend, Now Share Are Up

Boston, MA 10/18/2013 (wallstreetpr) – In the Q3.13 earnings report, Abbott Laboratories (NYSE:ABT) has succeed to beat analysts in their estimates and also excite its investor community. The earnings reflect three months performance for the trading period ending September 30, 2013.  The health care company has reported $0.55 earnings per share on revenue of $5.369 billion. Perhaps […]

Profits Down By 50% For Abbott Laboratories (NYSE:ABT)

Boston, MA 10/17/2013 (wallstreetpr) – Abbott Laboratories have been in a roller coaster ride for some months now but the biggest shock for the company was when its 3Q13 earnings fell almost 50% as a result of its specialty pharmaceuticals business, AbbVie Inc. The quarterly dividend was also raised by 57% to 22 cents per share […]

Major Drug Makers; Johnson & Johnson (JNJ) and Eli Lilly (LLY) Database Collaboration – JNJ, PFE, BMY, MRK, ABT

On Monday, current three major drug makers Eli Lilly & Co. (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), and Merck & Co., Inc. (NYSE:MRK) have decided to collaborate on a database that will assist speed up the investigational drug testing process. The firm will each contribute to a database, which will be made of doctors, hospitals and […]

Chromadex Gets A Supplemental Boost From Stock Guru (CDXC)

ChromaDex (OTC: CDXC), a natural products company, has gotten the attention of at least one world-class investor. Dr. Phillip Frost known for his sale of drug maker IVAX to TEVA (NYSE: TEVA) for $7.6 billion in 2005 has been accumulating shares of ChromaDex according to a news story released this afternoon. In June, Frost added […]